Rigattieri Stefano (9 results)

Hardcover. Condition: new. Hardcover. This book will cover all areas concerning the high bleeding risk and fragile patients (including CHIP). This milieu is becoming more and more common and requires specific attention and investment from the healthcare systems to be managed properly. The book will be divided into 4 macro-areas (coronary artery disease, valvular heart disease, peripheral arterial disease, high thrombotic risk patients), each of which include specific chapters on the latest technical advances, offering a thorough literature coverage as well. Additional sections are devoted to future diagnostic and therapeutic areas, depending on the disease and the patient's risk profile. Interventional cardiologists and cardiac surgeons dealing with PCI, coronary bypasses, left atrial appendage closure, aortic and mitral interventions in this patient subgroup will be provided with an overview of the latest techniques and innovative technologies in this area, that will help them improving the clinical outcome of their patients. The invited group of collaborators was selected from among the most experienced physicians in the world, from Asia, North and South America and Europe. The book will be divided into 4 macro-areas (coronary artery disease, valvular heart disease, peripheral arterial disease, high thrombotic risk patients), each of which include specific chapters on the latest technical advances, offering a thorough literature coverage as well. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condition: New.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will cover all areas concerning the high bleeding risk and fragile patients (including CHIP). This milieu is becoming more and more common and requires specific attention and investment from the healthcare systems to be managed properly. The book will be divided into 4 macro-areas (coronary artery disease, valvular heart disease, peripheral arterial disease, high thrombotic risk patients), each of which include specific chapters on the latest technical advances, offering a thorough literature coverage as well. Additional sections are devoted to future diagnostic and therapeutic areas, depending on the disease and the patient's risk profile. Interventional cardiologists and cardiac surgeons dealing with PCI, coronary bypasses, left atrial appendage closure, aortic and mitral interventions in this patient subgroup will be provided with an overview of the latest techniques and innovative technologies in this area, that will help them improving the clinical outcome of their patients. The invited group of collaborators was selected from among the most experienced physicians in the world, from Asia, North and South America and Europe.

Condition: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Hardcover. Condition: Brand New. 450 pages. 10.00x7.00x10.24 inches. In Stock.

Condition: new. Questo è un articolo print on demand.

Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Foreword.- Preface.- I- General concepts.- 1. The evolving phenotype of the patient undergoing interventional cardiology procedures.- 2. Prognostic Impact of Bleeding in Interventional Cardiology.- 3. From GUSTO to TIMI to BARC.- 4. The Conundrum between HBR and HTR.- II- Revascularization strategies in HBR patients.- 5. Percutaneous Coronary Intervention in the Elderly.- 6. Revascularisation Strategies in Frail Patients.- 7. Revascularization strategies in HBR patients: the selection of coronary stent.- 8. The DCB Philosophy.- 9. DCB: Clinical Data from Registries to Randomized Trials.- 10. Is there a potential advantage of DCB over DES, on the long term .- 11. Protected PCI in High Bleeding Risk Patients.- 12. Contemporary Bypass Techniques in Hybrid Revascularization.- 13. Hybrid Coronary Revascularization.- III- Structural heart interventions in HBR patients.- 14. Left atrial appendage closure: from randomized trials to contemporary registries.- 15. Tips and tricks for a successful and safe LAAO procedure.- 16. Transradial balloon aortic valvuloplasty.- 17. Minimalistic TAVI setup in high bleeding risk patients.- IV- Antithrombotic therapy in HBR patients.- 18. Intravenous Antiplatelet Drugs.- 19. Parenteral Anticoagulant Therapy.- 20. DAPT after coronary stenting: for how long and which drug.- 21. De-escalation of DAPT.- 22. Single antiplatelet therapy after DCB angioplasty.- 23. Triple or double antithrombotic therapy in Atrial Fibrillation patients treated with stents.- 24. Management and Prognostic Implications of Bleeding Post-TAVI.- V- Management and prognostic implications of bleedings in HBR patients.- 25. High bleeding risk in complex high risk and indicated patient.- 26. Antithrombotic Therapy after Transcatheter Aortic Valve Implantation or Left Atrial Appendage Occlusion.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 316 pp. Englisch.

Condition: New. Print on Demand.

Condition: New. PRINT ON DEMAND.